Injection Form of Remicade Biosimilar for IBD Similar to Approved Infusion, Phase 1 Trial Shows
News
A new formulation of CT-P13, a biosimilar of Remicade (infliximab), that is given as an under-the-skin (subcutaneous) injection, was shown to be as safe and effective in treating inflammatory bowel disease ... Read more